# Xerosis Treatment Market > Xerosis Treatment Market Research Report Information by Type (Medication [Antihistamines, Corticosteroids, Calcineurin Inhibitors, Anti-Inflammatory, Immunomodulators, and Others] and Personal Care Products), By Form (Tablets, Lotion, Cream, Cream, Ointment, Shower Forms, and Others), by Age Group (Paediatrics, Adults, and Elderly), By Gender (Male and Female), By Distribution Channel (Online and Offline) and by Region (North America, Europe, Asia-Pacific, South America, and Middle East and Africa) -Forecast till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.71% - **2024:** $ 45.51 Billion - **2025:** $ 49.02 Billion - **2035:** $ 103.02 Billion - **Key Players:** Johnson & Johnson (US), Bayer AG (DE), GlaxoSmithKline (GB), Pfizer Inc. (US), Novartis AG (CH), AbbVie Inc. (US), Sanofi (FR), Mylan N.V. (US), Eucerin (DE) **Report ID:** MRFR/HC/44629-CR · **Pages:** 208 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/xerosis-treatment-market-46310 --- ## Market Summary ##  Global Xerosis Treatment Market Overview Xerosis Treatment Market size was valued at USD 45.51 billion in 2024. The  Xerosis Treatment Market industry is projected to grow from USD 48.03 billion in 2025 to USD 82.45 billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.71% during the forecast period (2025 - 2035). The growth of the global market is being driven by increased awareness, better diagnostic capabilities, and innovative product formulations.  Source: Secondary Research, Primary Research, MRFR Database and Analyst Review ##  Xerosis Treatment Market Trend ### Rising awareness and improved diagnosis Rising awareness and improved diagnosis are playing a crucial role in accelerating the growth of the  Xerosis Treatment Market . Over the past few years, there has been a significant increase in public awareness about xerosis, a chronic skin condition characterized by dry, rough, and flaky skin. This surge in awareness has been fueled by a variety of factors, including widespread educational campaigns, the growing influence of digital media, and active involvement from healthcare professionals. As a result, more individuals are recognizing the symptoms of xerosis and seeking medical consultation for timely treatment. Enhanced access to information has also empowered patients to understand the importance of early diagnosis, which has led to the increased utilization of specialized treatments. The earlier the condition is identified, the more effective and efficient the treatment is, leading to higher demand for both over-the-counter and prescription-based solutions. Moreover, the  Xerosis Treatment Market is witnessing a surge in product launches as companies strive to meet the growing demand for effective solutions for dry skin conditions. With the increasing prevalence of xerosis and heightened awareness among both consumers and healthcare providers, pharmaceutical and skincare companies are introducing a wide range of innovative products, from topical emollients and moisturizers to advanced prescription therapies. These new product offerings are designed to address the diverse needs of xerosis patients, with formulations that provide enhanced hydration, improve skin barrier function, and offer long-lasting relief.  In conclusion, the  Xerosis Treatment Market is rapidly growing due to increased awareness and improved diagnosis of the condition. This has led to greater recognition of symptoms and earlier treatment, boosting demand for both over the counter and prescription solutions. The surge in product innovation reflects the market's response to the rising need for effective dry skin treatments. As awareness continues to grow, both consumers and healthcare providers will drive further advancements in treatment options. ##  Xerosis Treatment Market  Segment Insights ###  Xerosis Treatment Market Type Insights Based on type, the  Xerosis Treatment Market has been bifurcated into medication and personal care products. Medication is further segmented into antihistamines, [corticosteroids](../../../reports/corticosteroids-market-43141), calcineurin inhibitors, anti-inflammatory, immunomodulators, and others. The personal care products segment held the largest market share in 2024, and the medication segment is the fastest-growing segment during the forecast period (2025 -2035). Within the Medication category, there are several key subsegments, each catering to different aspects of xerosis (dry skin) treatment, depending on the severity and underlying causes of the condition. Antihistamines are usually prescribed in situations where xerosis is associated with allergic reaction or itching. These drugs will work by inhibiting histamine, which is a substance released in an allergic reaction, thereby decreasing the itching and irritation commonly present with dry skin conditions. Oral antihistamines such as diphenhydramine or cetirizine can be prescribed for the treatment of symptoms while topical antihistamines can be used for localized reactions on the skin. FIGURE 2:  Xerosis Treatment Market , BY TYPE, 2024 & 2035 (USD BILLION) Source: Secondary Research, Primary Research, MRFR Database and Analyst Review ###  Xerosis Treatment Market Form Insights Based on form, the  Xerosis Treatment Market has been segmented into tablets, lotion, cream, ointment, gels, shower foams, and others. The cream segment held the largest market in 2024, and the shower foams segment is the fastest growing segment during the forecast period. The tablets segment in the  Xerosis Treatment Market is driven by a growing prevalence of chronic conditions like diabetes, hypothyroidism, and other systemic disorders leading to severe dryness of the skin. Patients with such underlying health issues often require oral medications to treat the cause of xerosis, and hence, tablet-based treatments gain importance. Advances in systemic therapies specially targeted towards skin hydration and repair are further fueling tablet adoption in the segment. ###  Xerosis Treatment Market Age Group Insights Based on age group, the  Xerosis Treatment Market has been segmented into paediatrics, adults, and elderly. The adults segment held the largest market in 2024, and the elderly segment is the fastest growing segment during the forecast period. The paediatrics segment in the  Xerosis Treatment Market is mainly contributed by the increasing incidence of skin dryness and conditions such as eczema among children, largely attributed to genetic predisposition, environmental factors, and allergies. Parents increasingly want gentle, hypoallergenic products specifically designed for kids' sensitive skin. So, manufacturers have also promoted pediatric-friendly formulations devoid of harsh chemicals, fragrances, and dyes. Also, the rising consciousness of maintaining healthy skin from childhood and thereby preventing future complications is fueling the growth of segments. ###  Xerosis Treatment Market Gender Insights The female segment held the largest market in 2024, and the male segment is the fastest growing segment during the forecast period. The male segment in the  Xerosis Treatment Market is driven by the growing awareness among men about skin health and the importance of hydration in maintaining a healthy skin barrier. Men are becoming more proactive in addressing skin concerns, including xerosis, as societal norms around male grooming continue to evolve. The market has responded with gender-specific products, like light and non-greasy formulations, that can easily absorb into the skin quickly, according to men's preference. Long exposure to sunlight and occupational exposure are other environmental factors, which have a greater demand for targeted xerosis treatments among males. Campaigns by skincare brands for male grooming propel this growth segment. ###  Xerosis Treatment Market Distribution Channel Insights Based on distribution channel, the  Xerosis Treatment Market has been bifurcated into online and offline. The offline segment held the largest market in 2024, and the online segment is the fastest growing segment during the forecast period. The online distribution channels segment of the  Xerosis Treatment Market has experienced remarkable growth as consumers increasingly prefer online shopping platforms that provide convenience, accessibility, and a broad range of products. The e-commerce websites and online pharmacies have emerged as the prime B2C channels through which consumers can browse, compare, and purchase xerosis treatment products from the comfort of their homes. These platforms often provide detailed product descriptions, customer reviews, and discounts, which enhance the shopping experience and encourage adoption. ###  Xerosis Treatment Market Regional Insights By region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. The North American xerosis treatment market, covering Canada and Mexico, is seeing steady growth, driven by the rising demand for non-invasive treatments. Market growth in the region is mainly contributed by the increased incidence of xerosis and other similar conditions like eczema and psoriasis in both the US and Canada. For Instance, according to the National Psoriasis Foundation (US), More than 8 million people in the US are affected by psoriasis. This increased incidence of skin-related disorders has heightened the demand for effective treatments for dry skin, thereby boosting the market for xerosis treatment products in the region. The growing awareness about skincare, coupled with a significant shift towards self-care and natural remedies, further contributes to the surge in demand for both over the counter and prescription treatments. The availability of various treatment options, including lotions, creams, and medicated ointments, allows consumers to address symptoms of xerosis based on their needs, driving market expansion. Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia. FIGURE 3:  Xerosis Treatment Market , BY REGION, 2024 & 2035 (USD BILLION) Source: Secondary Research, Primary Research, MRFR Database and Analyst Review The growth of the xerosis treatment market in Europe is driven by the increasing prevalence of skin conditions such as xerosis, eczema, and psoriasis, especially in older populations. The European market is witnessing a rise in demand for both topical and oral treatments, fueled by growing awareness of skin health and the availability of a variety of treatment options. In particular, the, Germany, France, and UK account for a significant share of the market due to their advanced healthcare systems and widespread access to dermatological treatments. According to the European Academy of Dermatology and Venereology (EADV), at least 50% of people over the age of 65 suffer from xerosis, further fueling the demand for effective skincare solutions. In the Asia-Pacific (APAC) region, the market for xerosis treatment is growing due to increases in skin disorders, mainly in Japan, China, and India. Increased pollution levels, changing climate patterns, and urbanization contribute to a growing case of xerosis and related skin problems. In addition, the increasing concern about health and skincare is boosting the demand for medical and personal care products. The WHO reports that skin disorders and dry conditions are highly common in various APAC countries; therefore, the region is a significant target market for xerosis treatment solutions. Moreover, China xerosis treatment market held the largest market share in 2024, and Australia xerosis treatment market is the fastest growing market in the Asia-Pacific region. ##  Xerosis Treatment Market Key Market Players & Competitive Insights The  Xerosis Treatment Market is distinguished by the presence of numerous regional and local players catering to the  Xerosis Treatment Market . The market is distinguished by the existence of both prescription-based medicines and over the counter (OTC) drugs, which cater to a variety of customer needs. Larger companies use their established brand reputation, global distribution networks, and research capacity to maintain dominance, whereas smaller, specialized enterprises concentrate on producing limited, focused solutions with a particular emphasis on natural and organic ingredients. Competition has increased in response to rising demand for effective treatments, which is being driven by challenges such as aging populations and environmental influences on skin health. Amgen Inc. (Amgen) is a biotechnology firm that develops, creates, manufactures, and sells modern human therapeutics to treat people with life-threatening diseases. The company discovers, develops, manufactures and delivers innovative medicines aimed at combating some of the world’s most challenging diseases. They focus on areas with high unmet medical needs and leverage their expertise to create solutions that significantly improve patient outcomes and lessen the social and economic impact of illness. The company manufactures both biologics and small molecule drugs. Moreover, in August 2024, Amgen announced that Otezla (apremilast) is now available for pediatric use in the U.S. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Otezla for treating moderate to severe plaque psoriasis in children and adolescents aged 6 and older, weighing at least 20 kg (44 lb), and who are candidates for phototherapy or systemic therapy. ### Key Companies in the  Xerosis Treatment Market include **Pharmaceutical Excipients Industry Developments** August 2024: Amgen Inc. announced that Otezla (apremilast) is now available for pediatric use in the U.S. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Otezla for treating moderate to severe plaque psoriasis in children and adolescents aged 6 and older, weighing at least 20 kg (44 lb), and who are candidates for phototherapy or systemic therapy. January 2023: Olay has introduced the Niacinamide+Peptide 24 Face Moisturiser, a product packed with powerful niacinamide and amino acid peptides. Formulated with some of the most popular skincare ingredients of 2023, this moisturiser is the result of extensive research designed to meet consumer needs. **XEROSIS TREATMENT MARKET Segmentation** ** Xerosis Treatment Market Type Outlook** ** Xerosis Treatment Market Form Outlook** ** Xerosis Treatment Market Age Group Outlook** ** Xerosis Treatment Market Gender Outlook** ** Xerosis Treatment Market Distribution Channel Outlook** ** Xerosis Treatment Market Regional Outlook** - **North America** - **Europe** - **Asia-Pacific** - **South America** - Rest of South America ## Market Drivers ### Rising Healthcare Expenditure The upward trend in healthcare expenditure is a critical driver for the Xerosis Treatment Market. As individuals allocate more resources towards health and wellness, the demand for effective treatments for skin conditions like xerosis is likely to increase. Data suggests that healthcare spending has been on the rise, with many countries investing in dermatological care and treatment options. This trend is expected to enhance the availability of various xerosis treatments, including prescription medications and over-the-counter products. As consumers become more willing to invest in their skin health, the market is poised for substantial growth. ### Increasing Incidence of Xerosis The rising prevalence of xerosis, particularly among the elderly population, is a notable driver in the Xerosis Treatment Market. As skin conditions become more common with age, the demand for effective treatments is likely to escalate. Reports indicate that approximately 30% of older adults experience some form of dry skin, which necessitates a variety of treatment options. This growing demographic is expected to fuel market growth, as healthcare providers and consumers seek solutions to manage xerosis effectively. Furthermore, the increasing awareness of skin health among consumers is likely to contribute to the demand for specialized products, thereby enhancing the overall market landscape. ### Advancements in Dermatological Research Recent advancements in dermatological research are significantly influencing the Xerosis Treatment Market. Innovations in formulations and delivery systems have led to the development of more effective treatments for xerosis. For instance, the introduction of new emollients and moisturizers that penetrate deeper into the skin layers has shown promising results in clinical trials. This progress not only improves patient outcomes but also encourages healthcare professionals to recommend these advanced products. As a result, the market is witnessing a surge in the availability of novel treatments, which could potentially reshape consumer preferences and drive sales in the coming years. ### Increased Focus on Preventive Healthcare The growing emphasis on preventive healthcare is influencing the Xerosis Treatment Market. Consumers are increasingly recognizing the importance of maintaining skin health to prevent conditions such as xerosis. This shift in mindset is leading to a higher demand for preventive treatments and [skincare](https://www.marketresearchfuture.com/reports/skincare-market-14012) regimens that promote hydration and skin barrier function. Healthcare providers are also advocating for early intervention strategies, which could further drive the market as patients seek out products that help prevent the onset of dry skin. This proactive approach to skincare is likely to create new opportunities for manufacturers and expand the overall market. ### Growing Demand for Natural and Organic Products The increasing consumer preference for natural and organic products is reshaping the Xerosis Treatment Market. Many consumers are becoming more conscious of the ingredients in their skincare products, leading to a shift towards formulations that are perceived as safer and more effective. This trend is particularly evident among younger demographics, who are more inclined to choose products that are free from synthetic chemicals. Consequently, manufacturers are responding by developing a range of natural moisturizers and treatments that cater to this demand. The rise of e-commerce platforms has further facilitated access to these products, potentially expanding the market reach and driving growth. ## Future Outlook The Xerosis Treatment Market is projected to grow at a 7.71% CAGR from 2025 to 2035, driven by increasing prevalence of skin disorders, rising awareness, and advancements in treatment options. **New opportunities:** - Development of personalized skincare formulations targeting specific xerosis types. Expansion of [telehealth services](https://www.marketresearchfuture.com/reports/telehealth-service-market-43509) for remote patient consultations and follow-ups. Investment in biodegradable packaging for topical treatments to enhance sustainability. By 2035, the Xerosis Treatment Market is expected to achieve substantial growth, reflecting evolving consumer needs and innovative solutions. ## Segment Insights ### By Type: Medication (Largest) vs. Personal Care Products (Fastest-Growing) The Xerosis Treatment Market is primarily segmented into Medication and Personal Care Products. Within this landscape, Medication has emerged as the largest segment, capturing significant market share due to its essential role in managing the symptoms of xerosis. Personal Care Products are also witnessing increasing traction among consumers, reflecting a shift towards holistic skin care solutions. The demand for effective, easy-to-use products has allowed this segment to grow steadily, catering to diverse skin needs across various demographics. Xerosis Management: Medication (Dominant) vs. Personal Care Products (Emerging) Medication remains the dominant player in the Xerosis Treatment Market, primarily due to its scientifically validated efficacy in alleviating dry skin symptoms. Traditional treatments include corticosteroids and emollients, which provide targeted relief. Conversely, Personal Care Products, which include moisturizers and body washes specifically formulated for xerosis, represent an emerging segment that emphasizes preventive care and daily management. This segment has seen rapid growth, driven by a rising awareness of skin health and a preference for preventative treatments. Both segments address the needs of individuals suffering from xerosis, yet they cater to different aspects of treatment, combining medical and personal care approaches effectively. ### By Form: Cream (Largest) vs. Lotion (Fastest-Growing) In the Xerosis Treatment Market, the segmentation by form shows that creams hold the largest market share, attributed to their effectiveness in providing long-lasting hydration for dry skin conditions. Creams are preferred due to their rich texture, which seals moisture into the skin, making them ideal for intensive treatment. Lotions, while traditionally used, are gaining traction due to their lightweight formula that appeals to consumers preferring quick absorption without greasiness. These preferences shape the market landscape significantly. As the market evolves, the demand for lotions is rapidly escalating, positioning them as the fastest-growing segment in the Xerosis Treatment Market. Factors driving this trend include increased awareness of skin health and the preference for easy-to-apply, non-greasy formulations. The rise of dermatological recommendations and product innovations catering to sensitive skin types are also propelling the growth of this segment, indicating a shift towards lighter formulations in xerosis treatments. Cream (Dominant) vs. Lotion (Emerging) Creams in the Xerosis Treatment Market are recognized for their high viscosity and ability to deliver deep hydration, making them a dominant choice among consumers for treating moderately to severely dry skin conditions. Their formulation often includes occlusive agents that improve skin barrier function, which is crucial for xerosis patients. On the other hand, lotions, while currently emerging, are designed for users seeking convenience and lightweight application. They tend to provide adequate moisture without the heavy feel of creams, attracting a demographic that favors daily use over intensive treatment. With skincare moving towards multifunctional products, lotions that offer soothing and preventative benefits are quickly gaining popularity, particularly among younger consumers. ### By Age Group: Adults (Largest) vs. Elderly (Fastest-Growing) In the Xerosis Treatment Market, the age group segment shows significant variations, with Adults occupying the largest market share. This demographic comprises individuals aged 18 to 65 who experience xerosis due to various factors, such as lifestyle and environmental influences. Paediatrics, though essential, holds a smaller share, primarily driven by specific skin conditions prevalent in children. The Elderly segment, while comparatively smaller, is witnessing rapid growth due to the increasing elderly population worldwide and the rising awareness of skin health in older age. Adults (Dominant) vs. Elderly (Emerging) The Adults segment in the Xerosis Treatment Market is characterized by a diverse range of products addressing various causes of dry skin, from environmental factors to chronic conditions. Adults have a wide array of options available, including over-the-counter moisturizers and prescription treatments, tailored to different skin types and severity levels. Meanwhile, the Elderly segment is emerging rapidly, driven by the physiological changes associated with aging, which frequently result in increased skin dryness. This demographic shows a preference for comprehensive skincare solutions that not only address xerosis but also focus on anti-aging properties and overall skin health improvements. ### By Gender: Female (Largest) vs. Male (Fastest-Growing) The Xerosis Treatment Market is witnessing a significant distribution of market share between different genders. Female segment accounts for the largest share due to higher prevalence and awareness regarding skin conditions such as xerosis. This segment shows a consistent demand for moisturizing and hydrating products tailored to their skin needs, leading to an increased market presence. In contrast, the male segment, though smaller in immediate market share, is gaining traction with growing awareness and acceptance of skincare products specifically addressing xerosis. Campaigns aimed at educating men about skin health are contributing to this shift in market dynamics. Growth trends in the Xerosis Treatment Market indicate that while the female demographic continues to dominate, the male segment is emerging as a vital area of focus for skincare brands. Increased marketing efforts aimed at men and a societal shift towards personal grooming are driving growth in this demographic. Furthermore, the rise of online shopping channels is facilitating easier access to such products, making it a significant growth area for the market in the coming years. Gender: Female (Dominant) vs. Male (Emerging) In the context of the Xerosis Treatment Market, the female segment is deemed dominant due to its larger consumer base and comprehensive range of products designed to tackle skin dryness, typically characterized by higher investments in extensive marketing strategies that promote hydration and moisture-rich formulations. Women are more likely to seek treatments for xerosis, leading to an expansive line of products tailored to their unique dermatological needs. On the other hand, the male segment is emerging as a promising frontier, reflecting changing attitudes towards skincare among men. With increasing male consumer interest, brands are developing specialized products that cater specifically to male skin types, promoting faster growth rates and opening avenues for innovation in this traditionally underserved market. ### By Distribution Channel: Online (Largest) vs. Offline (Fastest-Growing) In the Xerosis Treatment Market, the distribution channel segment is primarily dominated by online sales, which have captured a significant share of the market. The ease of access and growing consumer preference for e-commerce have propelled online channels to the forefront. However, offline sales are witnessing remarkable growth, particularly in regions where consumers prefer in-person consultations and purchasing, indicating a diverse consumer base with varying shopping preferences. Distribution Channels: Online (Dominant) vs. Offline (Emerging) The online distribution channel has solidified its position as the dominant player in the Xerosis Treatment Market, thanks to its convenience and the ability to offer a wider range of products. Online platforms allow consumers to easily compare options and access reviews, driving informed purchasing decisions. In contrast, the offline channel is emerging rapidly, particularly in pharmacies and clinics, where personal interaction reinforces trust in treatment choices. This duality in distribution preferences highlights the importance of a balanced approach, catering to both tech-savvy consumers and those who prefer traditional purchase methods. ## Regional Market Share Analysis ### North America : Leading Market for Treatments North America is the largest market for [xerosis](https://www.marketresearchfuture.com/reports/xerosis-market-4039)treatment, accounting for approximately 45% of the global market share. The growth is driven by increasing awareness of skin conditions, a rise in the aging population, and advancements in dermatological treatments. Regulatory support from agencies like the FDA has also catalyzed innovation in product development, enhancing treatment options available to consumers. The United States is the primary contributor to this market, with significant investments from key players such as Johnson & Johnson and Pfizer Inc. The competitive landscape is characterized by a mix of established pharmaceutical companies and emerging biotech firms. The presence of advanced healthcare infrastructure and a focus on research and development further solidify North America's position as a leader in the xerosis treatment market. ### Europe : Regulatory Framework Enhances Growth Europe is the second-largest market for xerosis treatment, holding around 30% of the global market share. The region benefits from a robust regulatory framework that encourages innovation and ensures product safety. Increasing incidences of skin disorders and a growing emphasis on dermatological health are key drivers of market growth. The European Medicines Agency (EMA) plays a crucial role in regulating and approving new treatments, fostering a conducive environment for market expansion. Leading countries in this region include Germany, France, and the UK, where major players like Bayer AG and GlaxoSmithKline are actively involved. The competitive landscape is marked by a mix of multinational corporations and local firms, all striving to meet the rising demand for effective xerosis treatments. The presence of advanced healthcare systems and a focus on patient-centric solutions further enhance the market's potential. ### Asia-Pacific : Emerging Market with Potential The Asia-Pacific region is witnessing rapid growth in the xerosis treatment market, accounting for approximately 15% of the global share. Factors such as increasing urbanization, rising disposable incomes, and a growing awareness of skin health are driving demand. Additionally, the region's diverse climate conditions contribute to varying skin issues, further boosting the need for effective treatments. Regulatory bodies are gradually enhancing their frameworks to support market growth and product approvals. Countries like China, India, and Japan are leading the charge, with a mix of local and international players vying for market share. Companies such as AbbVie and Sanofi are expanding their presence in this region, focusing on innovative solutions tailored to local needs. The competitive landscape is evolving, with an increasing number of startups entering the market, driven by the demand for specialized dermatological products. ### Middle East and Africa : Untapped Market Opportunities The Middle East and Africa (MEA) region represents an emerging market for xerosis treatment, holding about 10% of the global market share. The growth is fueled by increasing awareness of skin health, rising healthcare expenditures, and a growing population. However, the market remains underdeveloped compared to other regions, presenting significant opportunities for growth. Regulatory bodies are beginning to implement frameworks that support the introduction of new treatments, which is expected to enhance market dynamics. Leading countries in this region include South Africa, UAE, and Saudi Arabia, where there is a growing demand for effective dermatological solutions. The competitive landscape is characterized by a mix of local and international players, with companies like Mylan N.V. and Eucerin making strides in product offerings. As healthcare infrastructure improves, the potential for market expansion in MEA is substantial, attracting investments from global firms. ## Competitive Benchmarking The  Xerosis Treatment Market is distinguished by the presence of numerous regional and local players catering to the  Xerosis Treatment Market . The market is distinguished by the existence of both prescription-based medicines and over the counter (OTC) drugs, which cater to a variety of customer needs. Larger companies use their established brand reputation, global distribution networks, and research capacity to maintain dominance, whereas smaller, specialized enterprises concentrate on producing limited, focused solutions with a particular emphasis on natural and organic ingredients. Competition has increased in response to rising demand for effective treatments, which is being driven by challenges such as aging populations and environmental influences on skin health. Amgen Inc. (Amgen) is a biotechnology firm that develops, creates, manufactures, and sells modern human therapeutics to treat people with life-threatening diseases. The company discovers, develops, manufactures and delivers innovative medicines aimed at combating some of the world’s most challenging diseases. They focus on areas with high unmet medical needs and leverage their expertise to create solutions that significantly improve patient outcomes and lessen the social and economic impact of illness. The company manufactures both biologics and small molecule drugs. Moreover, in August 2024, Amgen announced that Otezla (apremilast) is now available for pediatric use in the U.S. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Otezla for treating moderate to severe plaque psoriasis in children and adolescents aged 6 and older, weighing at least 20 kg (44 lb), and who are candidates for [phototherapy](https://www.marketresearchfuture.com/reports/phototherapy-market-1844) or systemic therapy. ## Recent News & Developments August 2024: Amgen Inc. announced that Otezla (apremilast) is now available for pediatric use in the U.S. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Otezla for treating moderate to severe plaque psoriasis in children and adolescents aged 6 and older, weighing at least 20 kg (44 lb), and who are candidates for phototherapy or systemic therapy. January 2023: Olay has introduced the Niacinamide+Peptide 24 Face Moisturiser, a product packed with powerful niacinamide and amino acid peptides. Formulated with some of the most popular skincare ingredients of 2023, this moisturiser is the result of extensive research designed to meet consumer needs. ## Report Scope | MARKET SIZE 2024 | 45.51(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 49.02(USD Billion) | | MARKET SIZE 2035 | 103.02(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.71% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Johnson & Johnson (US), Bayer AG (DE), GlaxoSmithKline (GB), Pfizer Inc. (US), Novartis AG (CH), AbbVie Inc. (US), Sanofi (FR), Mylan N.V. (US), Eucerin (DE) | | Segments Covered | Type, Form, Age Group, Gender, Distribution Channel, Region | | Key Market Opportunities | Emerging formulations and personalized therapies enhance treatment options in the Xerosis Treatment Market. | | Key Market Dynamics | Rising consumer awareness drives demand for innovative Xerosis treatments, influencing competitive dynamics and market strategies. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Xerosis Treatment Market as of 2024?** A: The Xerosis Treatment Market was valued at 45.51 USD Billion in 2024. **Q: What is the projected market size for the Xerosis Treatment Market by 2035?** A: The market is projected to reach 103.02 USD Billion by 2035. **Q: What is the expected CAGR for the Xerosis Treatment Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Xerosis Treatment Market during the forecast period 2025 - 2035 is 7.71%. **Q: Which companies are considered key players in the Xerosis Treatment Market?** A: Key players in the market include Johnson & Johnson, Bayer AG, GlaxoSmithKline, Pfizer Inc., Novartis AG, AbbVie Inc., Sanofi, Mylan N.V., and Eucerin. **Q: What are the primary segments of the Xerosis Treatment Market?** A: The primary segments include Type, Form, Age Group, Gender, and Distribution Channel. **Q: How much revenue did the Personal Care Products segment generate in 2024?** A: The Personal Care Products segment generated approximately 25.51 USD Billion in 2024. **Q: What is the revenue range for the Cream form of Xerosis treatment products?** A: The revenue range for the Cream form is between 15.0 and 35.0 USD Billion. **Q: Which age group contributes the most to the Xerosis Treatment Market?** A: The Adults age group contributed between 20.0 and 45.0 USD Billion in 2024. **Q: What is the revenue range for the Female gender segment in the Xerosis Treatment Market?** A: The Female gender segment generated between 27.31 and 62.02 USD Billion in 2024. **Q: What distribution channel is expected to dominate the Xerosis Treatment Market?** A: The Offline distribution channel generated between 27.31 and 61.02 USD Billion in 2024, indicating its dominance. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/xerosis-treatment-market-46310*